Utilizing Cohesive Bandage to Prevent Adverse Effects of Bleomycin Sclerotherapy: A Case Report

A A Pract. 2023 Sep 29;17(10):e01716. doi: 10.1213/XAA.0000000000001716. eCollection 2023 Oct 1.

Abstract

Sclerotherapy with bleomycin can cause cosmetic complications, including flagellate dermatitis and hyperpigmentation, induced or exacerbated by microtrauma to the skin. We report a case of a 9-year-old pediatric patient with congenital vascular malformations in which a cohesive bandage (eg, 3M Coban) was utilized to prevent bleomycin-induced hyperpigmentation. Postoperatively and on follow-up, there were no signs of hyperpigmentation or dermatitis in our patient. This report highlights using skin protective measures during bleomycin sclerotherapy for improved postoperative outcomes. If a patient is undergoing bleomycin sclerotherapy, consider removing adhesive where possible and using cohesive bandage to secure lines, airway instruments, and monitoring equipment.

Publication types

  • Case Reports

MeSH terms

  • Bandages
  • Bleomycin / adverse effects
  • Child
  • Dermatitis*
  • Humans
  • Hyperpigmentation*
  • Sclerotherapy / adverse effects

Substances

  • Bleomycin